Target intelligence / Profile preview

Cellular phospholipid synthesis pathway

Molecular classification
Other (metabolic pathway)
01

Overview

The cellular phospholipid synthesis pathway consists of enzymatic processes that produce the major phospholipids of biological membranes, including phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and others. These reactions primarily occur in the endoplasmic reticulum and also involve the Golgi apparatus and mitochondria for certain lipids. The pathway includes: - De novo synthesis, beginning from basic precursors such as glycerol-3-phosphate, leading to diacylglycerol and subsequent addition of different head groups. - Remodeling processes where existing phospholipids are modified, especially at the sn-2 position of their fatty acids, to maintain proper membrane fluidity and function. - Key enzymes include choline kinase, CTP:phosphocholine cytidylyltransferase (CT/CCT), phosphatidylserine synthase, phosphatidylethanolamine N-methyltransferase, and others. - Regulation is tight and multilayered, involving substrate availability, enzyme translocation, and feedback mediated by both lipids and signaling molecules. - The pathway is essential for cellular viability, organelle formation, intracellular signaling, and physiological adaptation. - Dysregulation or mutation of specific steps can be involved in multiple diseases, particularly those affecting tissues with high membrane turnover, such as the liver, nervous system, and rapidly proliferating cells. If you require information on a specific enzyme or molecular target within this pathway (e.g., "CTP:phosphocholine cytidylyltransferase" or "phosphatidylserine synthase"), clearer and more structured data can be provided for those well-defined entities.

Other names
Phospholipid biosynthesis pathwayDe novo phospholipid synthesisMembrane phospholipid synthesisGlycerophospholipid biosynthesis
02

Biological functions

Membrane biogenesisOrganelle structure maintenanceCell signalingLipid homeostasisApoptosis (indirectly, via phosphatidylserine exposure)Cell proliferation
03

Disease associations

Cancer (altered phospholipid metabolism)Neurodegenerative disease (membrane dysregulation)Cardiovascular diseaseMetabolic disease (e.g., steatohepatitis)Other (impaired membrane function or organelle biogenesis)

Beyond the preview

Go deeper on Cellular phospholipid synthesis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular phospholipid synthesis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call